Plasmodium vivax malaria elimination: Should innovative ideas from the past be revisited?

Memorias do Instituto Oswaldo Cruz

Volumn 109, Issue 5, 2014, Pages 522-524

  Val, Fernando Fonseca ^a,b   Sampaio, Vanderson Souza ^a,b   Cassera, Maria Belén ^c   Andrade, Raquel Tapajós ^a,b   Tauil, Pedro Luiz ^d   Monteiro, Wuelton Marcelo ^a,b   Lacerda, Marcus Vinícius Guimarães ^a,b  

^a FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^d UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Antimalarials; Control; Elimination; Malaria; Plasmodium; Salt

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; PRIMAQUINE;

BRAZIL; DRUG EFFECTS; DRUG RESISTANCE; HUMAN; MALARIA, VIVAX; PARASITOLOGY; PLASMODIUM VIVAX;

ANTIMALARIALS; BRAZIL; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX; PRIMAQUINE;

EID: 84906748233     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276140240     Document Type: Article

References (38)

1. Alecrim MGC, Alecrim W, Macêdo V 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon Region. Rev Soc Bras Med Trop 32: 67-68.
2. Baker DA 2010. Malaria gametocytogenesis. Mol Biochem Parasitol 172: 57-65.
3. Bousema T, Drakeley C 2011. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 24: 377-410.
4. Bowman JD, Merino EF, Brooks CF, Striepen B, Carlier PR, Cassera MB 2014. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the Malaria Box. Antimicrob Agents Chemother 58: 811-819.
5. Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, Foy BD 2013. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J 12: 153.
6. Clyde DF 1966. Suppression of malaria in Tanzania with the use of medicated salt. Bull World Health Organ 35: 962-968.
7. Coatney GR, Mickelsen O, Burgess RW, Young MD, Pirkle CI 1958. Chloroquine or pyrimethamine in salt as a supressive against sporozoite-induced vivax malaria (Chesson strain). Bull World Health Organ 19: 53-67.
8. da Silva R, Hochman G 2011. A method called Pinotti: medicated salt, malaria and international health (1952-1960). Hist Cienc Saude Manguinhos 18: 519-543.
9. Delves MJ 2012. Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs. Future Med Chem 4: 2251-2263.
10. Delves MJ, Plouffe D, Scheurer C, Meister S, Wittlin S, Winzeler EA, Sinden RE, Leroy D 2012. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med 9: e1001169.
11. Douglas NM, John GK, von Seidlein L, Anstey NM, Price RN 2012. Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria. Adv Parasitol 80: 271-300.
12. Duffy S, Avery VM 2013. Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar J 12: 408.
13. Giglioli G, Rutten FJ, Ramjattan S 1967. Interruption of malaria transmission by chloroquinized salt in Guyana with observations on a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ 36: 283-301.
14. Guiguemde WA, Shelat AA, Garcia-Bustos JF, Diagana TT, Gamo F-J, Guy RK 2012. Global phenotypic screening for antimalarials. Chem Biol 19: 116-129.
15. Hall SA, Wilks NE 1967. A trial of chloroquine-medicated salt for malaria suppression in Uganda. Am J Trop Med Hyg 16: 429-442.
16. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Möhrle JJ, Duparc S, Ugwuegbulam C, Kleim J-P, Carter N, Green JA, Kellam L 2013. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, Phase 2b dose-selection study. Lancet 383: 1049-1058.
17. Lobo CA, Kumar N 1998. Sexual differentiation and development in the malaria parasite. Parasitol Today 14: 146-150.
18. Majori G 2012. Short history of malaria and its eradication in Italy with short notes on the fight against the infection in the Mediterranean Basin. Mediterr J Hematol Infect Dis 4: e2012016.
19. Motabar M, Mofidi C, Saebi A, Ghiassedin M, Rouhani F 1971. A medicated salt project in the Kazeroun area, Iran-1962-1967. J Trop Med Hyg 74: 39-44.
20. Nosten F 2010. Waking the sleeping beauty. J Infect Dis 202: 1300-1301.
21. Pinotti M 1953. Chemoprophylaxis of malaria by the association of an antimalarial drug to the sodium chloride used daily in the preparation of meals. In V Congresso Internacional de Medicina Tropical e Malária, 28 Aug/4 Sep 1953, Istambul.
22. Pinotti M 1954. New method of malaria prevention: combination of an antimalarial drug with table salt used daily in food. Rev Bras Malariol Doencas Trop 6: 5-12.
23. Pinotti M 1959. The addition of antimalarial drugs to cooking salt: its importance in malaria eradication programmes. Triangle 4: 110-113.
24. Pinotti M, Lobo AG, Damasceno G, Soares R 1955a. Field tests of chloroquin-table salt mixture. Rev Bras Malariol Doencas Trop 7: 5-23.
25. Pinotti M, Soares R 1956. Eradication of malaria with chloroquine added to table salt. Rev Bras Malariol Doencas Trop 8: 253-265.
26. Pinotti M, Soares R, Monte R, Paulini E, Vinha C 1955b. Tests of chloroquine-table salt mixture in hospitalized patients. Rev Bras Malariol Doencas Trop 7: 25-36.
27. Santana Filho FS, Arcanjo ARL, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa MGV, Alecrim WD, Alecrim MGC 2007. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13: 1125-1126.
28. Sinden RE, Smalley ME 1979. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology 79: 277-296.
29. Smalley ME, Sinden RE 1977. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 74: 1-8.
30. Soares R 1955. Study of salt-chloroquine and follow-up program in hospitalized malaria patients. Rev Bras Malariol Doencas Trop 7: 281-303.
31. Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TNC, Willis P 2013. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS ONE 8: e62906.
32. Sun W, Tanaka TQ, Magle CT, Huang W, Southall N, Huang R, Dehdashti SJ, McKew JC, Williamson KC, Zheng W 2014. Chemical signatures and new drug targets for gametocytocidal drug development. Sci Rep 4: 3743.
33. Tauil PL 2011. The prospect of eliminating malaria transmission in some regions of Brazil. Mem Inst Oswaldo Cruz 106 (Suppl. I): 105-106.
34. malERA-Consultative Group on Basic Science and Enabling Technologies 2011. A research agenda for malaria eradication: basic science and enabling technologies. PLoS Med 8: e1000399.
35. UN-United Nations 2000. United Nations Millennium Declaration. In resolution adopted by the General Assembly, UN, New York, p. A/RES/55/2.
36. WHO-World Health Organization 2007. Malaria Elimination. A field manual for low and moderate endemic countries, WHO, Geneva, 98 pp.
37. WHO-World Health Organization 2012. WHO Evidence Review Group: the safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. Proceedings of the Malaria Policy Advisory Committee Meeting, 13-15 Aug 2012, Bangkok, Thailand, WHO, Geneva, 19 pp.
38. WHO-World Health Organization 2013. World malaria report 2013, WHO, Geneva, 284 pp.